The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?

Meet the experts

Leverage our scientific expertise to solve even the most challenging problems.

The journey from discovery to commercialization can be challenging. That's why we've assembled a team of scientists to share their insights and answer your questions on topics ranging from cold chain logistics and cGMP compliance in biologics manufacturing to technology transfers and more.

Easily search by category or expert to find the information you need.

Filter Clear all Results found
Expert
Market Category
Expert
Anil Kane, PhD, MBA
Senior Director, Global Technical and Scientific Affairs
Scientific Expertise:
  • Product development
  • Small molecules
  • Pre-formulation, clinical development to lifecycle management
  • Scientific strategic planning/problem solving
  • Early development
  • Clinical supplies
  • Technology transfer
  • Supporting chemistry, manufacturing, and controls documentation
Focus Area
Formulation and development
Credentials
Doctor of Philosophy from the University of Bombay, India Master of Business Administration from Richard Ivey School of Business, University of Western Ontario, Canada Post Doctoral research at the University of Cincinnati
Expert
Erica Byerley
Global Senior Tech Transfer Engineer
Scientific Expertise:
  • Single-use technology
  • Technology transfer
  • Process design
  • Operational readiness for biologics development through clinical manufacturing
Focus Area
Technology transfer
Credentials
Over eight years of industry experience, plus two degrees in chemical engineering and biological sciences
Expert
Kym Baker
Sr. Director/General Manager, Brisbane, Australia site
Scientific Expertise:
  • Leads our biologics manufacturing facility in Brisbane, Australia
  • Phase I through commercial manufacturing
  • Supports the product lifecycle from technology transfer to clinical and late-phase commercialization and manufacturing
  • R&D tax credits and the Clinical Trial Notification (CTN) scheme in Australia can help accelerate early-phase products to market
Focus Area
Biologics manufacturing
Credentials
PhD in immuno-vaccine development Over 30 years of experience in developing and manufacturing biologics